370 related articles for article (PubMed ID: 21791242)
1. Lethal factor is not required for Bacillus anthracis virulence in guinea pigs and rabbits.
Levy H; Weiss S; Altboum Z; Schlomovitz J; Rothschild N; Blachinsky E; Kobiler D
Microb Pathog; 2011 Nov; 51(5):345-51. PubMed ID: 21791242
[TBL] [Abstract][Full Text] [Related]
2. The effect of deletion of the edema factor on Bacillus anthracis pathogenicity in guinea pigs and rabbits.
Levy H; Weiss S; Altboum Z; Schlomovitz J; Rothschild N; Glinert I; Sittner A; Kobiler D
Microb Pathog; 2012 Jan; 52(1):55-60. PubMed ID: 22020310
[TBL] [Abstract][Full Text] [Related]
3. Differential contribution of Bacillus anthracis toxins to pathogenicity in two animal models.
Levy H; Weiss S; Altboum Z; Schlomovitz J; Glinert I; Sittner A; Shafferman A; Kobiler D
Infect Immun; 2012 Aug; 80(8):2623-31. PubMed ID: 22585968
[TBL] [Abstract][Full Text] [Related]
4. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
Chitlaru T; Israeli M; Rotem S; Elia U; Bar-Haim E; Ehrlich S; Cohen O; Shafferman A
Vaccine; 2017 Oct; 35(44):6030-6040. PubMed ID: 28342664
[TBL] [Abstract][Full Text] [Related]
5. HtrA is a major virulence determinant of Bacillus anthracis.
Chitlaru T; Zaide G; Ehrlich S; Inbar I; Cohen O; Shafferman A
Mol Microbiol; 2011 Sep; 81(6):1542-59. PubMed ID: 21801240
[TBL] [Abstract][Full Text] [Related]
6. Next-Generation Bacillus anthracis Live Attenuated Spore Vaccine Based on the htrA(-) (High Temperature Requirement A) Sterne Strain.
Chitlaru T; Israeli M; Bar-Haim E; Elia U; Rotem S; Ehrlich S; Cohen O; Shafferman A
Sci Rep; 2016 Jan; 6():18908. PubMed ID: 26732659
[TBL] [Abstract][Full Text] [Related]
7. Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits.
Lee DY; Chun JH; Ha HJ; Park J; Kim BS; Oh HB; Rhie GE
FEMS Immunol Med Microbiol; 2009 Nov; 57(2):165-72. PubMed ID: 19732139
[TBL] [Abstract][Full Text] [Related]
8. Capsules, toxins and AtxA as virulence factors of emerging Bacillus cereus biovar anthracis.
Brézillon C; Haustant M; Dupke S; Corre JP; Lander A; Franz T; Monot M; Couture-Tosi E; Jouvion G; Leendertz FH; Grunow R; Mock ME; Klee SR; Goossens PL
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003455. PubMed ID: 25830379
[TBL] [Abstract][Full Text] [Related]
9. Construction of a rhamnose mutation in Bacillus anthracis affects adherence to macrophages but not virulence in guinea pigs.
Bozue JA; Parthasarathy N; Phillips LR; Cote CK; Fellows PF; Mendelson I; Shafferman A; Friedlander AM
Microb Pathog; 2005 Jan; 38(1):1-12. PubMed ID: 15652290
[TBL] [Abstract][Full Text] [Related]
10. Bacillus cereus G9241 makes anthrax toxin and capsule like highly virulent B. anthracis Ames but behaves like attenuated toxigenic nonencapsulated B. anthracis Sterne in rabbits and mice.
Wilson MK; Vergis JM; Alem F; Palmer JR; Keane-Myers AM; Brahmbhatt TN; Ventura CL; O'Brien AD
Infect Immun; 2011 Aug; 79(8):3012-9. PubMed ID: 21576337
[TBL] [Abstract][Full Text] [Related]
11. Activity of the Bacillus anthracis 20 kDa protective antigen component.
Hammamieh R; Ribot WJ; Abshire TG; Jett M; Ezzell J
BMC Infect Dis; 2008 Sep; 8():124. PubMed ID: 18808698
[TBL] [Abstract][Full Text] [Related]
12. Ratio of lethal and edema factors in rabbit systemic anthrax.
Molin FD; Fasanella A; Simonato M; Garofolo G; Montecucco C; Tonello F
Toxicon; 2008 Dec; 52(7):824-8. PubMed ID: 18812184
[TBL] [Abstract][Full Text] [Related]
13. Molecular dynamics simulations of complexes between wild-type and mutant anthrax protective antigen variants and a model anthrax toxin receptor.
Stiles L; Nelson DJ
J Biomol Struct Dyn; 2005 Apr; 22(5):503-19. PubMed ID: 15702923
[TBL] [Abstract][Full Text] [Related]
14. Expression of either lethal toxin or edema toxin by Bacillus anthracis is sufficient for virulence in a rabbit model of inhalational anthrax.
Lovchik JA; Drysdale M; Koehler TM; Hutt JA; Lyons CR
Infect Immun; 2012 Jul; 80(7):2414-25. PubMed ID: 22526673
[TBL] [Abstract][Full Text] [Related]
15. The two-component system Bacillus respiratory response A and B (BrrA-BrrB) is a virulence factor regulator in Bacillus anthracis.
Vetter SM; Schlievert PM
Biochemistry; 2007 Jun; 46(25):7343-52. PubMed ID: 17536838
[TBL] [Abstract][Full Text] [Related]
16. CodY regulation is required for full virulence and heme iron acquisition in Bacillus anthracis.
Château A; van Schaik W; Six A; Aucher W; Fouet A
FASEB J; 2011 Dec; 25(12):4445-56. PubMed ID: 21911592
[TBL] [Abstract][Full Text] [Related]
17. Discriminating virulence mechanisms among Bacillus anthracis strains by using a murine subcutaneous infection model.
Chand HS; Drysdale M; Lovchik J; Koehler TM; Lipscomb MF; Lyons CR
Infect Immun; 2009 Jan; 77(1):429-35. PubMed ID: 18981254
[TBL] [Abstract][Full Text] [Related]
18. Catalytically inactive anthrax toxin(s) are potential prophylactic agents.
Gupta M; Alam S; Bhatnagar R
Vaccine; 2007 Dec; 25(50):8410-9. PubMed ID: 17980467
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of non-toxic deletion mutants of protective antigen from Bacillus anthracis.
Rhie GE; Park YM; Han JS; Yu JY; Seong WK; Oh HB
FEMS Immunol Med Microbiol; 2005 Aug; 45(2):341-7. PubMed ID: 16019195
[TBL] [Abstract][Full Text] [Related]
20. Lethal factor, but not edema factor, is required to cause fatal anthrax in cynomolgus macaques after pulmonary spore challenge.
Hutt JA; Lovchik JA; Drysdale M; Sherwood RL; Brasel T; Lipscomb MF; Lyons CR
Am J Pathol; 2014 Dec; 184(12):3205-16. PubMed ID: 25285720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
